- 2024 - 2027 成人T細胞白血病に対するCRISPR-Cas13を用いた遺伝子治療戦略の開発
- 2024 - 2027 AIとイメージングでEMT型膵癌の機能を定量化しCRISPRで機能的RNAを狙う新規治療の探索
- 2024 - 2027 成人自己炎症性疾患VEXAS症候群の病態解明およびCas13を用いた革新的遺伝子治療の開発
- 2022 - 2027 CRISPR/dCas13システムを用いた革新的がん治療戦略の構築
- 2024 - 2026 The lncRNA landscape of skeletal muscle cell biotransformation with aging.
- 2022 - 2025 制御性T細胞の変化が関わるシェーグレン症候群特異的な新規非翻訳RNAの探索と解析
- 2020 - 2023 Development of irregular X-chromosome inactivation-specific targeted therapy
- 2019 - 2022 Development of new combined cancer immunotherapy for malignant soft tissue tumor
- 2018 - 2021 Development of a New Evaluation Method for Exercise Training Using Mitochondrial Activation of Peripheral Blood Mononuclear Cells
- 2018 - 2021 Biological effect and preventive method for human serum albumin binding to transboundary air borne PM2.5.
- 2017 - 2021 Practical Application of Cancer Suppressor BAP1 Activity as a Biomarker for Malignant Mesothelioma
- 2016 - 2018 PM protein 1 may be one of transboundary environmental factor.
- 2011 - 2012 Identifidcation of Runx2 arginine methylation as a potent of target for osteosarcoma
Show all